Wednesday, August 23, 2017

Forest Labs rises on data for bipolar mania drug

October 5, 2011 by  
Filed under Depression

Shares of Forest Laboratories Inc. rose Wednesday after the company said its experimental bipolar disorder drug, cariprazine, met its goal in a late-stage clinical study.

Speak Your Mind

Tell us what you're thinking...
and oh, if you want a pic to show with your comment, go get a gravatar!